Natco to Launch Semaglutide Generic at 90 Percent Discount in India
Natco Pharma is set to launch a generic version of semaglutide in India at a sharply reduced price, signalling the start of an intense price competition in the diabetes and weight-loss drug segment.
Natco | 20/03/2026 | By Darshana | 115
NATCO receives final approval for Tipiracil Hydrochloride and Trifluridine for the US market
NATCO receives final approval for Tipiracil Hydrochloride and Trifluridine for the US market
NATCO | 19/06/2023 | By Sudeep Soparkar | 1029
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy